Solventum Corp SOLV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.® Therapy
-
Solventum to Participate in Upcoming Investor Conferences
-
Solventum autonomous coding listed in Epic Toolbox
-
Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance
-
3M's stock has its best day on record as upbeat outlook underscores fresh start
-
Solventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
-
3M's stock drops after CFO resigns, 2 months after new CEO was appointed
-
U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings
Trading Information
- Previous Close Price
- $69.22
- Day Range
- $67.88–69.05
- 52-Week Range
- $47.16–96.05
- Bid/Ask
- $61.18 / $69.25
- Market Cap
- $11.76 Bil
- Volume/Avg
- 2.0 Mil / 1.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 10.13
- Price/Sales
- 1.43
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Mid Value
- Total Number of Employees
- 22,000
- Website
- https://www.3m.com
Comparables
Valuation
Metric
|
SOLV
|
AGL
|
CYH
|
---|---|---|---|
Price/Earnings (Normalized) | 10.13 | — | 11.62 |
Price/Book Value | 4.10 | 2.27 | — |
Price/Sales | 1.43 | 0.30 | 0.06 |
Price/Cash Flow | 7.64 | — | 1.28 |
Price/Earnings
SOLV
AGL
CYH
Financial Strength
Metric
|
SOLV
|
AGL
|
CYH
|
---|---|---|---|
Quick Ratio | 0.86 | 1.32 | 1.14 |
Current Ratio | 1.31 | 1.36 | 1.47 |
Interest Coverage | — | −32.76 | 1.27 |
Quick Ratio
SOLV
AGL
CYH
Profitability
Metric
|
SOLV
|
AGL
|
CYH
|
---|---|---|---|
Return on Assets (Normalized) | 3.18% | −7.62% | −0.19% |
Return on Equity (Normalized) | 13.17% | −21.88% | — |
Return on Invested Capital (Normalized) | 3.88% | −19.92% | 5.57% |
Return on Assets
SOLV
AGL
CYH
Health Information Services Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
GE HealthCare Technologies Inc Common Stock
GEHC
| Chthfsfv | Rvy | $42.2 Bil | |||
Veeva Systems Inc Class A
VEEV
| Gwlvhfykl | Hxmb | $33.9 Bil | |||
Pro Medicus Ltd
PMCUF
| — | Vzmydj | $12.3 Bil | |||
Tempus AI Inc Class A common stock
TEM
| — | Mgmhg | $8.0 Bil | |||
Doximity Inc Class A
DOCS
| — | Xqppwp | $7.9 Bil | |||
M3 Inc
MTHRF
| — | Whwgg | $6.9 Bil | |||
M3 Inc ADR
MTHRY
| — | Ffwrhlt | $6.9 Bil | |||
HealthEquity Inc
HQY
| — | Dcjslf | $6.9 Bil | |||
R1 RCM Inc
RCM
| — | Nzykw | $6.0 Bil |